Literature DB >> 19816377

Sequential treatment of speech disorders in velocardiofacial syndrome patients: an 8-year retrospective evaluation.

Guomin Wang1, Ke Wang, Yang Chen, Yusheng Yang, Yilai Wu, Liping Jiang, Haiosng Xu, Kenneth E Salyer.   

Abstract

BACKGROUND: Speech disorders are the most common presentations of patients with velocardiofacial syndrome (VCFS) and are difficult to be treated with very good treatment outcome. The purpose of this study was to evaluate the clinical diagnosis and outcomes of sequential treatment of therapy for VCFS.
METHODS: A retrospective study of 120 patients (ages ranged from 4.3 to 38 years old, with a mean age of 10.2 years) was conducted and thoroughly reviewed retrospectively oral speech evaluation, oral examinations, and lateral cephalometry of 33 patients. Comparison was made in 33 patients (age range, 4-17 years; mean age, 7.24 years); patients were compared with and age-matched controls, using IQ scores and speech intelligibility tests. A Chinese speech intelligibility test and blowing test were also used to evaluate the outcomes of modified pharyngeal flap surgery, behavioral therapy, and speech therapy.
RESULTS: The average age of the primary diagnosis for VCFS was 13.9 years. No cleft palate and reduced mobility in pharyngeal function were found by oral examination. Speech intelligibility in the 33 patients with VCFS was 33%, with an average IQ test score of 67. Chinese speech intelligibility of 33 patients who underwent pharyngoplasty and speech therapy was improved from 47% to 98%, and the duration of blowing test increased from 17 to 38 seconds. The average length of therapy period was estimated to be 8 months.
CONCLUSIONS: Hypernasality and reduced mobility in palate and pharyngeal structures of VCFS patients could be measured with Chinese speech intelligibility test and blowing tests. The pharyngeal flap surgery and the behavioral therapy are proved to be an effective protocol for VCFS.

Entities:  

Mesh:

Year:  2009        PMID: 19816377     DOI: 10.1097/SCS.0b013e3181b6cc9c

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  2 in total

Review 1.  In search of the optimal surgical treatment for velopharyngeal dysfunction in 22q11.2 deletion syndrome: a systematic review.

Authors:  Nicole E Spruijt; Judith Reijmanhinze; Greet Hens; Vincent Vander Poorten; Aebele B Mink van der Molen
Journal:  PLoS One       Date:  2012-03-28       Impact factor: 3.240

2.  Self-reported speech problems in adolescents and young adults with 22q11.2 deletion syndrome: a cross-sectional cohort study.

Authors:  Nicole E Spruijt; Jacob As Vorstman; Moshe Kon; Aebele B Mink van der Molen
Journal:  Arch Plast Surg       Date:  2014-09-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.